anxiety

EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting

...study of PRX-00023 in 311patients with generalized anxiety disorder (GAD). Top-line resultsfrom the trial wer...023 showed a trend(p=0.116) to reduce the level of anxiety versus placebo based onthe HAM-A; data from the trial also indicated a statisticallysignificant chan...

Indevus Announces Presentation of Pagoclone Data at 47th Annual New Clinical Drug Evaluation Unit Meeting

...week 4 and week 8, is a validated measureof social anxiety symptoms. Stuttering is often co-morbid withsymptoms of social anxiety which can be a disabling consequence ofstuttering. Although patients with primary anxiety disorders ...

Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study

...for thetreatment of depression and a wide range of anxiety disorders,"said Senior Vice President Anders Gersel Pedersen, Head ofDevelopment at Lundbeck. "These new data provide further evidenceof the strong efficacy and tolerability profile of Cipralex®compared to other antidepressants in the treatment o...

Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo

...atment of major depressive disorderand generalized anxiety disorder; Namenda(R) (memantine HCl), anN-methyl D- aspartate (NMDA)-receptor antagonist indicated for thetreatment of moderate to severe Alzheimer's disease; Benicar(R)*(olmesartan medoxomil), an angiotensin receptor blocker, andBenicar* HCT(R) (olm...

In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression

...e Willige G.Recognition, management, and course of anxiety and depression ingeneral practice. Arch Gen Psychiatry. 1991;48:700–706. 13 Simon GE et al. An International Study of the Relation BetweenSomatic Symptoms and Depression. New Engl J Med.1999;341(18):1329-35. 14 Paykel ES, et al. Psychol Med. 19...

Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia

... placebo, respectively: headache (30% vs 25%), anxiety (20% vs 17%), insomnia (19% vs 14%), nausea (16% vs 12%), vomiting (12% vs 6%), dizziness (11% vs 8%), constipation (11% vs 7%), dyspepsia (10% vs 8%), and akathisia (10% vs 4%). Aripiprazole Injection In short-term (24 hour) tria...

Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse

...dditionally, many people withADHD also suffer from anxiety disorders and depression. Therefore,proper diagnosis of all a patient's symptoms is vital for choosingappropriate treatment and monitoring for both safety andefficacy.(3,4,5) About Strattera Strattera, a selective norepinephrine reuptake inhibitor,...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome

...atment of major depressive disorder andgeneralized anxiety disorder; Namenda(R) (memantine HCl), anN-methyl D- aspartate (NMDA)-receptor antagonist indicated for thetreatment of moderate to severe Alzheimer's disease; Benicar(R)*(olmesartan medoxomil), an angiotensin receptor blocker, andBenicar* HCT(R) (olm...

Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo

...reaterimprovement in mild and moderate symptoms of anxiety associatedwith depression compared with those who ... depressive disorder, patients were excluded ifany anxiety disorder was the primary diagnosis. Eligible patientswere randomly assigned to the desvenlafaxine su...

Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants

...lacebo, respectively: headache (30% vs 25%), anxiety (20% vs 17%), insomnia (19% vs 14%), nausea (16% vs 12%), vomiting (12% vs 6%), dizziness (11% vs 8%), constipation (11% vs 7%), dyspepsia (10% vs 8%), and akathisia (10% vs 4%). Aripiprazole Injection In short-term (24 ...

Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder

...all/ -- Datasuggest that patients with generalized anxiety disorder (GAD)treated with Cymbalta(R) (duloxetine...toms and 7 percent was fromimprovements in somatic anxiety associated with GAD. Since GAD presents with a variety of symptoms, it can bedifficult to diagnose(...

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

...nt of major depressivedisorder and for generalized anxiety disorder in adults; Namenda(R)(memantine HCI), an N-methyl-D-aspartate (NMDA)-receptor antagonistindicated for the treatment of moderate to severe Alzheimer'sdisease; Benicar(R)** (olmesartan medoxomil), an angiotensinreceptor blocker indicated for t...

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy

...atmentof major depressive disorder and generalized anxiety disorder;Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptorantagonist indicated for the treatment of moderate to severeAlzheimer's disease; Benicar(R)* (olmesartan medoxomil), anangiotensin receptor blocker, and Benicar* HCT(R) (olme...

New Survey Finds Troubling Data on American Asthma Sufferers

...eriencing a great deal of emotional upset or anxiety during an asthma flare-up compared to other adults and parents of child sufferers (6 percent, 8 percent). For more detailed survey findings, as well as NCL's neweducational materials for asthma patients and parents, visit<a target="_blank"...

Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting

...sideredserious: influenza, sepsis and anxiety. The anxiety was consideredprobably related to treatment. A focal seizure, observed during thesepsis, was considered possibly related to treatment. An additional13 patients in the Fampridine-SR-treated group experienced variousserious adverse events but none of t...

Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain

...erception, as well as itseffects on depression and anxiety symptoms, may be due toincreasing the activity of ...lneuropathic pain and the treatment of generalized anxiety disorder,all in adults. Cymbalta is not approved for use in pediatricpatients. Important Safety Inf...

Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show

...approved in Europe for thetreatment of generalized anxiety disorder. DISCLOSURE NOTICE: The information contained in this release isas of May 1, 2007. Pfizer assumes no obligation to updateforward-looking statements contained in this release as the resultof new information or future events or developments. ...

Study Sheds Light on Medication Treatment Options for Bipolar Disorder

... for co-existing disorders such as substanceabuse, anxiety or psychotic symptoms. Such open recruitmentcriteria allows the studys results to have broader applicabilitythan a tightly controlled trial in which people are excluded fromparticipating if they have co-existing disorders. Before participants were r...

MUSC Research Offers Hope for Those Resistant to Depression Treatment

...ious stages of researchas potential treatments for anxiety disorders, Alzheimer's disease,bulimia, chronic headache/migraine and morbid obesity. CONTACT: Tim Gehret of Medical University of SouthCarolina,+1-843-792-2626 Web site: <a target="_blank" href="http://www.musc.edu/">http://www.musc.edu/ ...

In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression

... States andMexico for the treatment of generalised anxiety disorder.Duloxetine is approved only for adults 18...mmonadverse reactions in patients with generalised anxiety disordertreated with duloxetine in clinical trials were nausea, fatigue,dry mouth, drowsiness, const...